Given the large scope (14 long-answer questions + 10 MCQs), I'll provide comprehensive answers from my biochemistry and physiology knowledge, organized clearly by question.
GAZI MEDICAL COLLEGE — 2nd Term Final Examination
Biochemistry: Metabolism & Body Fluids
GROUP-A
Q1. Main Constituents of Gastric Juice; Stomach Protection Against High Acidity; HCl Secretion (2+1+2)
Main Constituents of Gastric Juice and Their Functions
| Constituent | Function |
|---|
| HCl | Acidifies stomach (pH 1–2), activates pepsinogen → pepsin, kills microorganisms, denatures proteins |
| Pepsinogen | Inactive precursor; activated to pepsin by HCl; pepsin begins protein digestion |
| Intrinsic Factor (from parietal cells) | Binds vitamin B12 for absorption in terminal ileum |
| Mucus (from mucous neck cells) | Coats gastric mucosa, protects against acid and pepsin |
| Gastric lipase | Partial digestion of triglycerides |
| Water & electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻) | Solvent medium |
Protection Against High Gastric Acidity (Gastric Mucosal Barrier)
- Mucus layer — thick, viscous gel forms a physical barrier over epithelium
- Bicarbonate secretion — mucous cells secrete HCO₃⁻, neutralizing acid at the epithelial surface
- Tight junctions — between epithelial cells prevent back-diffusion of H⁺
- Rapid cell turnover — damaged cells replaced every 3–5 days
- Prostaglandins (E2, I2) — stimulate mucus and HCO₃⁻ secretion, maintain mucosal blood flow
How HCl is Secreted (Parietal Cell Mechanism)
- Carbonic anhydrase converts CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻
- H⁺/K⁺-ATPase (proton pump) on luminal surface actively pumps H⁺ into stomach lumen in exchange for K⁺
- Cl⁻ exits via apical Cl⁻ channels into lumen alongside H⁺ → forming HCl
- HCO₃⁻ exchanges for Cl⁻ on basolateral side (the "alkaline tide")
- Stimulated by: histamine (H₂ receptors), gastrin, acetylcholine (vagus)
- Inhibited by: omeprazole (blocks proton pump), ranitidine (H₂ blocker), somatostatin
Q2. Digestion of Protein; Absorption of End Products (3+2)
Digestion of Protein
In Stomach:
- HCl denatures proteins (unfolding)
- Pepsinogen → pepsin (by HCl and autocatalysis)
- Pepsin: endopeptidase, cleaves peptide bonds at aromatic amino acids (Phe, Tyr, Trp) → polypeptides
In Small Intestine (Pancreatic Enzymes — Duodenum/Jejunum):
| Enzyme | Type | Activation | Cleaves |
|---|
| Trypsinogen | Endopeptidase | By enteropeptidase (enterokinase) → trypsin | Arg, Lys bonds |
| Chymotrypsinogen | Endopeptidase | By trypsin → chymotrypsin | Phe, Tyr, Trp bonds |
| Proelastase | Endopeptidase | By trypsin → elastase | Ala, Val, Gly bonds |
| Procarboxypeptidase A & B | Exopeptidase (C-terminal) | By trypsin | C-terminal residues |
Brush Border Enzymes (intestinal mucosal cells):
- Aminopeptidases — remove N-terminal amino acids from peptides
- Dipeptidases — cleave dipeptides → free amino acids
- End products: free amino acids, dipeptides, tripeptides
Absorption of End Products
- Free amino acids: absorbed by Na⁺-dependent active transport (co-transport with Na⁺) via specific carriers (neutral, basic, acidic, imino acid transporters) on brush border → enter portal blood
- Dipeptides and tripeptides: absorbed via PepT1 transporter (H⁺-dependent) → hydrolyzed to amino acids inside enterocytes
- Amino acids enter the portal vein → liver for metabolism
- Some amino acids (Lys, Arg) share transporters (e.g., cystinuria results from defective basic amino acid transporter)
Q3. Components and Arrangements of ETC (Electron Transport Chain); Importance and Inhibitors (3+2)
Components and Arrangement of ETC
The ETC is located on the inner mitochondrial membrane and consists of four protein complexes + two mobile carriers:
NADH → Complex I → CoQ → Complex III → Cyt c → Complex IV → O₂ → H₂O
FADH₂ → Complex II → CoQ ↗
| Complex | Name | Prosthetic Groups | Function |
|---|
| Complex I | NADH dehydrogenase (NADH-CoQ reductase) | FMN, Fe-S clusters | Transfers 2e⁻ from NADH to CoQ; pumps 4H⁺ |
| Complex II | Succinate dehydrogenase (Succinate-CoQ reductase) | FAD, Fe-S, cytochrome b | Transfers 2e⁻ from FADH₂ to CoQ; no proton pumping |
| Complex III | Cytochrome bc1 (CoQ-Cyt c reductase) | Cyt b, Cyt c1, Fe-S | Transfers e⁻ from CoQ to Cyt c; pumps 4H⁺ |
| CoQ (Ubiquinone) | Mobile carrier | Benzoquinone ring | Shuttles e⁻ between CI/CII and CIII |
| Cytochrome c | Mobile carrier | Heme c | Shuttles e⁻ from CIII to CIV |
| Complex IV | Cytochrome c oxidase | Cyt a, a3, Cu centers | Transfers e⁻ to O₂ → H₂O; pumps 2H⁺ |
| Complex V (ATP synthase) | F₀F₁-ATPase | — | Uses proton gradient (chemiosmosis) to synthesize ATP |
Importance of ETC
- Major source of ATP: NADH yields ~2.5 ATP; FADH₂ yields ~1.5 ATP
- Drives oxidative phosphorylation — the cell's primary energy currency production
- Creates proton motive force (electrochemical gradient) across inner mitochondrial membrane
- Generates heat (thermogenesis), especially uncoupled in brown adipose tissue
- Essential for aerobic life; without it, only anaerobic glycolysis available (2 ATP/glucose vs ~30–32 ATP)
Inhibitors of ETC
| Inhibitor | Site of Action | Mechanism |
|---|
| Rotenone, Amytal (barbiturates) | Complex I | Block NADH → CoQ transfer |
| Malonate | Complex II | Competitive inhibitor of succinate dehydrogenase |
| Antimycin A | Complex III | Blocks CoQ → Cyt c transfer |
| Cyanide (CN⁻), CO, Azide (N₃⁻), H₂S | Complex IV | Bind Fe-a3/Cu of cytochrome oxidase; block O₂ reduction |
| Oligomycin | Complex V (F₀) | Blocks proton channel; stops ATP synthesis |
| DNP (dinitrophenol), Thermogenin | Inner membrane | Uncouplers — dissipate proton gradient as heat; no ATP made |
Q4. HMP Shunt: Definition, Importance, Clinical Importances of Shunt Pathway (1+3+1)
What is HMP Shunt?
The Hexose Monophosphate (HMP) shunt (also called Pentose Phosphate Pathway / Phosphogluconate pathway) is an alternative pathway of glucose oxidation that occurs in the cytosol. It does not produce ATP but generates NADPH and pentose sugars.
- Rate-limiting enzyme: Glucose-6-phosphate dehydrogenase (G6PD)
- Two phases: Oxidative (irreversible, generates NADPH + CO₂) and Non-oxidative (reversible, interconverts sugars)
Importance of HMP Shunt
-
NADPH generation — essential for:
- Reductive biosynthesis (fatty acid synthesis, cholesterol synthesis, steroid synthesis)
- Maintaining reduced glutathione (GSH) — protects RBCs from oxidative hemolysis
- Cytochrome P450 reactions (drug detoxification in liver)
- NADPH oxidase in phagocytes (respiratory burst — killing bacteria)
- Nitric oxide synthesis
-
Ribose-5-phosphate production — precursor for nucleotide and nucleic acid synthesis (DNA, RNA, ATP, NAD, FAD, CoA)
-
Interconversion of sugars — non-oxidative phase provides 3C, 4C, 5C, 6C, 7C sugars for glycolysis and other pathways
-
Active in tissues requiring high NADPH — liver, adrenal cortex (steroidogenesis), mammary gland (lactation), RBCs, phagocytes
Clinical Importances
-
G6PD Deficiency — most common enzyme deficiency in humans (X-linked). Without NADPH, RBCs cannot regenerate GSH → oxidative damage → hemolytic anemia triggered by drugs (primaquine, dapsone), infections, fava beans
-
Favism — hemolysis in G6PD-deficient individuals after eating fava beans
-
Chronic Granulomatous Disease (CGD) — NADPH oxidase deficiency → phagocytes cannot produce superoxide → recurrent severe bacterial/fungal infections
-
Pentosuria — defect in non-oxidative phase → xylulose-5-phosphate excreted in urine (benign condition)
Q5. Transamination, Oxidative Deamination, Importance of Each, Ammonia Intoxication (2+2+1)
Transamination
Definition: Transfer of an α-amino group from an amino acid to an α-keto acid, forming a new amino acid and a new keto acid. No free ammonia is released.
Coenzyme: Pyridoxal phosphate (PLP) — derived from Vitamin B6
Example:
Aspartate + α-Ketoglutarate ⇌ Oxaloacetate + Glutamate
(catalyzed by AST — Aspartate aminotransferase)
Alanine + α-Ketoglutarate ⇌ Pyruvate + Glutamate
(catalyzed by ALT — Alanine aminotransferase)
Importance of Transamination:
- Channels amino groups into glutamate (central amino acid)
- Provides non-essential amino acids by synthesis
- Links amino acid and carbohydrate metabolism
- ALT and AST are important liver function markers in clinical diagnosis
Oxidative Deamination
Definition: Removal of an amino group from an amino acid with oxidation, releasing free NH₃ and the corresponding α-keto acid.
Key Enzyme: Glutamate dehydrogenase (GDH) in liver mitochondria
Example:
Glutamate + NAD⁺ (or NADP⁺) → α-Ketoglutarate + NH₃ + NADH
Importance of Oxidative Deamination:
- Primary mechanism of free ammonia generation in the body
- Linked to transamination via glutamate (transamination–deamination tandem)
- NH₃ is then converted to urea (in liver) for excretion
- Regenerates α-ketoglutarate for TCA cycle
Ammonia Intoxication
- Normally, blood NH₃ < 35 μmol/L; urea cycle in liver detoxifies it
- Causes of elevated NH₃: liver failure, urea cycle enzyme defects, portosystemic shunts, urease-producing bacteria
- Mechanism of toxicity:
- NH₃ combines with α-ketoglutarate → glutamate → depletes TCA cycle intermediate (α-KG), impairing brain energy (ATP) production
- Excess glutamate → glutamine (trapping α-KG) → astrocyte swelling (cerebral edema)
- Altered neurotransmitter balance (GABA, glutamate)
- Features: asterixis (flapping tremor), confusion, stupor, coma — hepatic encephalopathy
Q6. 2-Year-Old with Diarrhea, Abdominal Discomfort, Flatulence After Milk — Causes and Enzyme (4+1)
Possible Causes (Differential Diagnosis)
This clinical picture after milk ingestion in a 2-year-old points to carbohydrate malabsorption, most likely:
- Primary (Congenital) Lactase Deficiency — rare, presents at birth
- Secondary Lactase Deficiency — most common in this age group; follows gastroenteritis (rotavirus), celiac disease, Giardia infection, or any mucosal injury that destroys brush border enzymes
- Congenital sucrase-isomaltase deficiency — if sucrose also causes symptoms
- Cow's milk protein allergy — immune-mediated; causes vomiting, diarrhea, blood in stool
- Galactosemia — enzyme defect preventing galactose metabolism (jaundice, liver disease in neonates)
Most Likely Diagnosis: Lactose Intolerance (Lactase Deficiency)
Mechanism:
- Normally, lactase (β-galactosidase) on intestinal brush border cleaves lactose → glucose + galactose
- In deficiency, undigested lactose passes to colon
- Colonic bacteria ferment lactose → short-chain fatty acids + CO₂ + H₂ and lactic acid
- Results in: osmotic diarrhea (lactose osmotically draws water), flatulence (gas from fermentation), bloating/abdominal discomfort
Responsible Enzyme
Lactase (β-D-galactosidase / lactase-phlorizin hydrolase)
- Location: brush border of small intestinal enterocytes (jejunum)
- Normally highest at birth, declines after weaning in most populations (lactase non-persistence)
- Secondary lactase deficiency: reduced after mucosal damage
Q7. Ketone Bodies, Ketoacidosis in DM, β-Oxidation of Fatty Acids, ATP from 18-C Saturated FA (2+1+2+1+2+2)
Ketone Bodies — Definition and Use in the Body
Three ketone bodies made in hepatic mitochondria:
- Acetoacetate — primary KB; can be used directly
- β-hydroxybutyrate (3-hydroxybutyrate) — reduced form; predominates
- Acetone — spontaneous decarboxylation of acetoacetate; exhaled
How they are used:
- Transported in blood to extrahepatic tissues (brain, heart, skeletal muscle, kidney cortex)
- Converted back to Acetyl-CoA via succinyl-CoA transferase (thiophorase) → enter TCA cycle
- The liver cannot use its own ketone bodies (lacks thiophorase)
- Important fuel during prolonged fasting, starvation, and uncontrolled diabetes
Ketoacidosis in Uncontrolled Diabetes Mellitus
- In uncontrolled T1DM: absolute insulin deficiency → cells cannot take up glucose
- Glucagon/insulin ratio rises → lipolysis ↑ → massive FFAs released from adipose tissue → liver
- Liver β-oxidizes excess FFAs → huge Acetyl-CoA accumulation
- Oxaloacetate (OAA) is diverted to gluconeogenesis → TCA cycle cannot accept Acetyl-CoA
- HMG-CoA pathway overwhelmed → excess ketone bodies → ketonemia
- Ketones are acidic (pKa ~3.5) → metabolic acidosis (pH ↓, HCO₃⁻ ↓)
- Features: Kussmaul breathing, fruity breath (acetone), hyperglycemia, polyuria, dehydration, anion gap metabolic acidosis
β-Oxidation of Fatty Acids
Definition: Stepwise oxidative removal of 2-carbon (acetyl-CoA) units from the carboxyl end of a fatty acyl chain, occurring in the mitochondrial matrix.
Steps (one cycle, removes one acetyl-CoA from C-chain):
| Step | Enzyme | Reaction | Yield |
|---|
| 1. Acyl-CoA dehydrogenase | Acyl-CoA dehydrogenase (FAD-linked) | Acyl-CoA → trans-Δ²-Enoyl-CoA | 1 FADH₂ |
| 2. Hydration | Enoyl-CoA hydratase | Enoyl-CoA → L-3-Hydroxyacyl-CoA | — |
| 3. Oxidation | L-3-Hydroxyacyl-CoA dehydrogenase (NAD-linked) | Hydroxyacyl-CoA → 3-Ketoacyl-CoA | 1 NADH |
| 4. Thiolysis | Thiolase (β-ketothiolase) | 3-Ketoacyl-CoA + CoA → Acetyl-CoA + acyl-CoA (2C shorter) | 1 Acetyl-CoA |
Cycle repeats until all carbons are acetyl-CoA units.
Activation: Fatty acid + CoA + ATP → Acyl-CoA + AMP + PPi (costs 2 ATP equivalents)
Entry into mitochondria: Carnitine shuttle (carnitine acyl transferase I & II)
ATP Calculation for 18-Carbon Saturated FA (Stearic Acid)
Step 1 — Activation: −2 ATP equivalents
Step 2 — Number of β-oxidation cycles:
- 18C FA → 9 Acetyl-CoA units
- Cycles needed = 9 − 1 = 8 cycles
Step 3 — Yield per cycle × 8 cycles:
- 8 FADH₂ × 1.5 ATP = 12 ATP
- 8 NADH × 2.5 ATP = 20 ATP
Step 4 — Acetyl-CoA → TCA cycle:
- 9 Acetyl-CoA × 10 ATP = 90 ATP
Step 5 — Total:
| Source | ATP |
|---|
| From β-oxidation (FADH₂) | 12 |
| From β-oxidation (NADH) | 20 |
| From TCA (9 Acetyl-CoA) | 90 |
| Subtotal | 122 |
| Activation cost | −2 |
| Net ATP | 120 ATP |
---# GROUP-B
Q8. Tubular Load, Renal Threshold, Transport Maximum; Peculiarities of Renal Blood Flow (3+2)
Tubular Load
The total amount of a substance delivered to the renal tubules per unit time via glomerular filtration.
Tubular Load = GFR × Plasma concentration of substance
Example: For glucose: GFR = 125 mL/min, plasma glucose = 1 mg/mL → Tubular load = 125 mg/min
Renal Threshold
The plasma concentration at which a substance first appears in urine (i.e., when tubular load exceeds reabsorptive capacity and the substance "spills" into urine).
- For glucose: ~180 mg/dL (the glucose threshold — below this, all filtered glucose is reabsorbed)
- Threshold may vary among nephrons (explains why some glucose appears in urine before Tm is reached — "splay" in titration curve)
Transport Maximum (Tm)
The maximum rate at which the tubules can reabsorb a substance per unit time — represents saturation of carrier proteins.
- TmG (glucose) = ~375 mg/min (male) — above this, all additional filtered glucose appears in urine
- Once Tm is exceeded, reabsorption plateaus and urinary excretion increases linearly with plasma concentration
Peculiarities of Renal Blood Flow
- Two capillary beds in series: glomerular capillaries (high pressure ~60 mmHg for filtration) → efferent arteriole → peritubular capillaries (low pressure for reabsorption)
- Autoregulation: RBF and GFR are maintained constant over mean arterial pressure 80–180 mmHg via myogenic mechanism and tubuloglomerular feedback (macula densa)
- High blood flow relative to organ size: kidneys receive ~20–25% of cardiac output (1200 mL/min) but represent only 0.5% of body weight
- High O₂ delivery but modest extraction: renal venous blood still O₂-rich (kidneys don't extract much O₂ per volume)
- Vasa recta in medulla: hairpin loop structure maintains medullary osmotic gradient for concentration of urine (countercurrent exchange)
- Juxtaglomerular apparatus: specialized region controlling renin secretion and GFR
Q9. Daily Water Intake and Output Chart; Water Turnover; Calculation (3+2)
Daily Water Intake and Output Chart (Adult, ~70 kg)
| INTAKE | Volume (mL/day) |
|---|
| Drinking water and beverages | 1200 |
| Water in food | 1000 |
| Metabolic (oxidation) water | 300 |
| Total Intake | ~2500 mL/day |
| OUTPUT | Volume (mL/day) |
|---|
| Urine | 1500 |
| Insensible loss (skin) | 500 |
| Insensible loss (lungs/expired air) | 300 |
| Feces | 100 |
| Sweat (minimal at rest) | 100 |
| Total Output | ~2500 mL/day |
(Note: In fever, exercise, hot climate → sweat increases significantly)
Obligatory Water Loss
Minimum urine needed to excrete daily solute load = ~500 mL/day (minimum urine output)
Water Turnover
Definition: The total volume of water turned over (replaced) per unit time, reflecting both intake and loss. In adults: ~2–2.5 L/day at rest.
Calculation:
Water turnover can be measured by the isotope dilution method using deuterium oxide (D₂O) or tritiated water (³H₂O):
- Give a known dose of D₂O orally
- Allow equilibration (~3–4 hours)
- Measure the concentration of D₂O in plasma/urine
- Total body water (TBW) = Dose administered / Concentration at equilibrium
- TBW ≈ 60% of body weight in males (42 L in 70 kg man)
- Water turnover rate = daily intake or output / TBW × 100%
Q10. Electrolyte Profile with Reference Ranges; Common Causes of Hyponatremia; Consequences (2+2+1)
Electrolyte Profile with Reference Ranges
| Electrolyte | Reference Range |
|---|
| Na⁺ (Sodium) | 135–145 mmol/L |
| K⁺ (Potassium) | 3.5–5.0 mmol/L |
| Cl⁻ (Chloride) | 98–107 mmol/L |
| HCO₃⁻ (Bicarbonate) | 22–26 mmol/L |
| Ca²⁺ (Calcium, total) | 2.2–2.6 mmol/L (8.5–10.5 mg/dL) |
| Mg²⁺ (Magnesium) | 0.7–1.0 mmol/L |
| PO₄³⁻ (Phosphate) | 0.8–1.5 mmol/L |
Common Causes of Hyponatremia (Na⁺ < 135 mmol/L)
1. Hypovolemic hyponatremia (Na⁺ and water both lost, but Na⁺ > water):
- Vomiting, diarrhea, burns
- Adrenal insufficiency (Addison's disease)
- Diuretic use (thiazides especially)
2. Euvolemic hyponatremia (water retained, Na⁺ normal):
- SIADH (Syndrome of Inappropriate ADH secretion) — most common cause
- Hypothyroidism
- Psychogenic polydipsia
3. Hypervolemic hyponatremia (both water and Na⁺ increased, but water > Na⁺):
- Congestive heart failure
- Nephrotic syndrome
- Liver cirrhosis
4. Pseudohyponatremia — artefact in severe hyperlipidemia or hyperproteinemia
Consequences of Hyponatremia
- Cellular edema — osmotic water shift into cells (low ECF osmolality → water moves into cells)
- Brain: cerebral edema → headache, nausea, confusion, seizures, coma, herniation (life-threatening)
- Muscle weakness and fatigue
- Severe (Na⁺ < 120 mmol/L) → seizures, respiratory arrest, death
- ⚠️ Rapid correction → Central Pontine Myelinolysis (osmotic demyelination syndrome)
Q11. Plasma Anion Gap; Measured & Unmeasured Cations and Anions; Causes of Increased Anion Gap (1+2+2)
Plasma Anion Gap (AG)
Definition: The difference between the commonly measured cations and anions in plasma; represents "unmeasured anions."
AG = Na⁺ − (Cl⁻ + HCO₃⁻)
Normal AG = 8–12 mEq/L (or up to 16 if K⁺ excluded)
(Electroneutrality is always maintained — the gap is not a real gap but represents unmeasured anions)
Measured and Unmeasured Ions
Measured Cations: Na⁺, (K⁺)
Unmeasured Cations: Ca²⁺, Mg²⁺, immunoglobulins (positively charged)
Measured Anions: Cl⁻, HCO₃⁻
Unmeasured Anions (account for normal anion gap): Albumin (most important), phosphate, sulfate, organic acids
Causes of Increased Anion Gap (High AG Metabolic Acidosis)
Mnemonic: MUDPILES or KULT
| Cause | Unmeasured Anion |
|---|
| Methanol poisoning | Formate |
| Uremia (renal failure) | Sulfate, phosphate, organic acids |
| Diabetic ketoacidosis (DKA) | β-hydroxybutyrate, acetoacetate |
| Propylene glycol toxicity | Lactate |
| Isoniazid / Iron overdose | Lactate |
| Lactic acidosis | Lactate |
| Ethylene glycol poisoning | Glycolate, oxalate |
| Salicylate (aspirin) poisoning | Salicylate, lactate |
| Starvation/alcoholic ketoacidosis | Ketoacids |
Q12. Classification of Primary Acid-Base Disorders; Causes and Compensation of Respiratory Acidosis (2+3)
Classification of Primary Acid-Base Disorders
| Disorder | pH | Primary Change | Compensation |
|---|
| Respiratory Acidosis | ↓ (<7.35) | ↑ PaCO₂ (>45 mmHg) | ↑ HCO₃⁻ (renal) |
| Respiratory Alkalosis | ↑ (>7.45) | ↓ PaCO₂ (<35 mmHg) | ↓ HCO₃⁻ (renal) |
| Metabolic Acidosis | ↓ (<7.35) | ↓ HCO₃⁻ (<22 mEq/L) | ↓ PaCO₂ (hyperventilation) |
| Metabolic Alkalosis | ↑ (>7.45) | ↑ HCO₃⁻ (>26 mEq/L) | ↑ PaCO₂ (hypoventilation) |
Respiratory Acidosis
Definition: Decrease in blood pH due to accumulation of CO₂ (hypercapnia) from hypoventilation or impaired CO₂ excretion.
Causes:
CNS Depression (reduced respiratory drive):
- Opiates, sedatives, barbiturates, anesthetics
- Brainstem lesions, trauma
Neuromuscular:
- Guillain-Barré syndrome, myasthenia gravis
- Muscular dystrophy, diaphragm paralysis
Airway/Pulmonary:
- COPD (most common chronic cause)
- Severe asthma, status asthmaticus
- Pneumonia, pulmonary edema, pneumothorax
- Upper airway obstruction (foreign body, laryngospasm)
Chest Wall:
- Kyphoscoliosis
- Flail chest
Compensation for Respiratory Acidosis
Immediate (minutes — blood buffers):
- CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻
- H⁺ buffered by hemoglobin and plasma proteins
- Modest rise in HCO₃⁻: ~1 mEq/L per 10 mmHg rise in PaCO₂ (acute)
Delayed (2–5 days — renal compensation):
- Kidney proximal tubule: ↑ H⁺ secretion → ↑ HCO₃⁻ reabsorption
- Kidney distal tubule: ↑ NH₄⁺ excretion, ↑ titratable acid
- HCO₃⁻ rises ~3.5 mEq/L per 10 mmHg rise in PaCO₂ (chronic)
- Expected HCO₃⁻ in chronic resp. acidosis = 24 + 3.5 × (PaCO₂ − 40)/10
Q13. Clinical Case: pH 7.52, HCO₃⁻ 32 mmol/L, PCO₂ 48 mmHg in Woman with Persistent Vomiting (2+3)
Step 1 — Identify the Acid-Base Disorder
| Parameter | Value | Normal | Direction |
|---|
| pH | 7.52 | 7.35–7.45 | ↑ → Alkalosis |
| HCO₃⁻ | 32 mmol/L | 22–26 | ↑ → Metabolic |
| PCO₂ | 48 mmHg | 35–45 | ↑ (compensatory hypoventilation) |
Diagnosis: Metabolic Alkalosis with Respiratory Compensation
Interpretation:
- pH is alkalotic + primary rise in HCO₃⁻ → Metabolic Alkalosis
- PCO₂ elevated (48 mmHg) = appropriate respiratory compensation (hypoventilation to retain CO₂)
- Check compensation: Expected PCO₂ = 40 + 0.7 × (HCO₃⁻ − 24) = 40 + 0.7 × 8 = 45.6 mmHg ≈ matches (48 close to expected — appropriate compensation, not a mixed disorder)
Cause: Persistent vomiting → loss of HCl → loss of H⁺ and Cl⁻ → rise in plasma HCO₃⁻
Other Causes of Metabolic Alkalosis
Chloride-responsive (urine Cl⁻ < 15 mEq/L):
- Vomiting / nasogastric suction (most common) — loss of HCl
- Diuretic use (loop, thiazide) — loss of Cl⁻ and K⁺
- Post-hypercapnic alkalosis
- Villous adenoma of colon (Cl⁻ losing diarrhea)
Chloride-resistant (urine Cl⁻ > 25 mEq/L):
- Primary hyperaldosteronism (Conn's syndrome) — ↑ H⁺ and K⁺ excretion
- Cushing's syndrome (excess cortisol with mineralocorticoid activity)
- Severe hypokalemia (K⁺ shifts into cell, H⁺ shifts out)
- Bartter's/Gitelman's syndrome (hereditary renal tubular disorders)
- Exogenous alkali (excessive NaHCO₃, antacid ingestion)
- Milk-alkali syndrome
Q14. Hormones Acting on Kidney; Acidification of Urine (PCT vs DCT); Glycosuria in DM; Limiting pH of Urine (3+3+2+2)
Hormones Acting on the Kidney and Their Functions
| Hormone | Source | Action on Kidney |
|---|
| ADH (Vasopressin) | Posterior pituitary | Inserts aquaporin-2 (AQP2) in collecting duct → ↑ water reabsorption → concentrated urine |
| Aldosterone | Adrenal cortex (zona glomerulosa) | ↑ Na⁺ reabsorption and K⁺/H⁺ secretion in distal tubule and collecting duct |
| PTH (Parathyroid hormone) | Parathyroid glands | ↑ Ca²⁺ reabsorption in DCT; ↓ phosphate reabsorption (PCT); ↑ 1α-hydroxylase (activates vitamin D) |
| Atrial Natriuretic Peptide (ANP) | Atria | ↑ Na⁺ and water excretion; ↓ renin and aldosterone; dilates afferent arteriole |
| Renin → Angiotensin II | JG cells of kidney | Vasoconstriction; stimulates aldosterone; ↑ Na⁺ reabsorption in PCT directly |
| Insulin | Pancreas β-cells | ↑ Na⁺ reabsorption in PCT |
| Dopamine | Adrenal medulla / renal nerves | ↑ Na⁺ and water excretion (natriuretic) |
| Erythropoietin (EPO) | Peritubular cells | Stimulates RBC production in bone marrow |
| 1,25-(OH)₂ Vitamin D | Kidney (1α-hydroxylase) | ↑ Ca²⁺ and phosphate absorption in gut |
Acidification of Urine: PCT vs DCT
Proximal Convoluted Tubule (PCT):
- Reabsorbs ~80–85% of filtered HCO₃⁻
- H⁺ secreted via Na⁺/H⁺ exchanger (NHE3) — antiporter (secondary active)
- H⁺ + HCO₃⁻ (luminal) → H₂CO₃ → CO₂ + H₂O (catalyzed by carbonic anhydrase IV on brush border)
- CO₂ diffuses into cell; regenerated to HCO₃⁻ intracellularly (by CA II); HCO₃⁻ exits basolaterally
- Cannot lower urine pH below 6.0 — buffer system prevents extreme acidification
- Major role: HCO₃⁻ reclamation, not net acid excretion
Distal Convoluted Tubule (DCT) and Collecting Duct:
- Type A (α) intercalated cells secrete H⁺ via H⁺-ATPase (primary active) and H⁺/K⁺-ATPase on luminal surface
- This is net acid secretion (not just HCO₃⁻ reclamation)
- H⁺ is buffered in lumen by:
- Phosphate buffer (H₂PO₄⁻ → titratable acid)
- NH₃ (secreted by tubular cells) + H⁺ → NH₄⁺ (trapped and excreted)
- Can acidify urine to pH 4.5–5.0
- Aldosterone stimulates H⁺ secretion here
- Type B intercalated cells secrete HCO₃⁻ (for alkalinization when needed)
Summary Comparison:
| Feature | PCT | DCT/Collecting Duct |
|---|
| Primary mechanism | NHE3 (Na⁺/H⁺ exchanger) | H⁺-ATPase (primary active) |
| Main role | HCO₃⁻ reclamation | Net acid secretion |
| Buffers used | HCO₃⁻ | Phosphate (titratable acid), NH₃/NH₄⁺ |
| Minimum urine pH achievable | ~6.0 | ~4.5 |
| Regulation | Angiotensin II, carbonic anhydrase | Aldosterone, K⁺ balance |
Why Glycosuria Occurs in Diabetes Mellitus
- Glucose is normally filtered at glomerulus and completely reabsorbed in PCT via SGLT2 (sodium-glucose cotransporter 2) and SGLT1
- Renal threshold for glucose = ~180 mg/dL
- In DM, blood glucose >> 180 mg/dL → tubular load exceeds Tm (~375 mg/min)
- Excess filtered glucose cannot be reabsorbed → spills into urine (glycosuria)
- Glycosuria causes osmotic diuresis (glucose osmotically retains water in tubule) → polyuria → polydipsia
Limiting pH of Urine
- Maximum urinary acidification = pH 4.5 (minimum pH)
- Maximum urinary alkalinization = pH ~8.0–8.5
- The lower limit (pH 4.5) is set by the maximum H⁺ gradient the H⁺-ATPase in intercalated cells can maintain against the concentration gradient
- Below pH 4.5, the back-diffusion of H⁺ equals secretion — no further net acidification possible
MCQ PAPER — True/False + SBA (20 marks, 30 minutes)
(Questions 1–10 are True/False; Questions 11–20 are Single Best Answer — the SBA questions 11–20 are not visible in the image, so I will answer Q1–10 True/False below)
Questions 1–10: True (T) / False (F)
Q1. Cholesterol —
| Statement | T/F | Explanation |
|---|
| a) is synthesized in plants | F | Plants synthesize phytosterols (e.g., β-sitosterol), not cholesterol. Cholesterol is an animal sterol |
| b) is a derived lipid | T | Derived lipids are products of hydrolysis of simple/compound lipids — cholesterol is classified as a derived lipid (sterol) |
| c) is an antioxidant | F | Cholesterol is not an antioxidant; it is a membrane stabilizer and steroid precursor |
| d) is synthesized by intestinal flora | F | Intestinal flora do not synthesize cholesterol; humans synthesize it (primarily in liver) |
| e) acts as precursor of bile acid and vitamin D | T | Cholesterol → bile acids (in liver) and → vitamin D (skin, UV light → cholecalciferol) and → steroid hormones |
Q2. Salient Features of HMP Shunt —
| Statement | T/F | Explanation |
|---|
| a) Glucose-1-phosphate is the substrate | F | The substrate is Glucose-6-phosphate (G6P), not G1P |
| b) De-oxyribose sugar is the product | F | The product is ribose-5-phosphate (pentose), not deoxyribose (which is made by ribonucleotide reductase) |
| c) It is anabolic in nature | F | HMP shunt is primarily catabolic (oxidative phase degrades G6P) and amphibolic (non-oxidative phase is reversible); though NADPH generated supports anabolism |
| d) ATP is produced | F | HMP shunt does not produce ATP; it produces NADPH and ribose-5-phosphate |
| e) Glucose-6-phosphate dehydrogenase is the rate-limiting enzyme | T | G6PD is the first and rate-limiting enzyme of the oxidative phase of HMP shunt |
Q3. Ketone Bodies —
| Statement | T/F | Explanation |
|---|
| a) are lipid soluble | F | Ketone bodies (acetoacetate, β-hydroxybutyrate) are water-soluble (hydrophilic); this allows them to be transported freely in blood without carriers |
| b) act as metabolic fuel | T | Ketone bodies are important alternative fuels for brain, heart, skeletal muscle (especially during fasting/starvation) |
| c) are synthesized in liver | T | Ketogenesis occurs exclusively in hepatic mitochondria |
| d) may be synthesized in skeletal muscle | F | Skeletal muscle cannot synthesize ketone bodies (lacks HMG-CoA synthase mitochondrial isoform); it only utilizes them |
| e) are produced in persistent vomiting | F | Persistent vomiting → metabolic alkalosis, not ketosis. Ketone bodies are produced in starvation, DKA, prolonged fasting |
Q4. Proteolytic Enzymes —
| Statement | T/F | Explanation |
|---|
| a) pepsin | T | Pepsin is a proteolytic enzyme (endopeptidase) secreted by chief cells of stomach |
| b) pancreatic lipase | F | Lipase is a lipolytic (fat-digesting) enzyme, not proteolytic |
| c) trypsin | T | Trypsin is a proteolytic enzyme (endopeptidase) from the pancreas |
| d) lactase | F | Lactase is a carbohydrate-digesting (glycolytic) enzyme that cleaves lactose; not proteolytic |
| e) aminopeptidase | T | Aminopeptidase is a brush border proteolytic (exopeptidase) enzyme that removes N-terminal amino acids |
Q5. Favoring Forces of GFR —
| Statement | T/F | Explanation |
|---|
| a) Bowman's capsule hydrostatic pressure | F | Bowman's capsule hydrostatic pressure (capsular pressure) opposes filtration (acts against GFR) |
| b) Capillary colloidal osmotic pressure | F | Glomerular capillary oncotic pressure (colloidal osmotic pressure) opposes filtration (draws water back in) |
| c) Filtration co-efficient (Kf) | T | Kf (permeability × surface area) is a multiplier that favors and determines the magnitude of GFR |
| d) Glomerular capillary hydrostatic pressure | T | Glomerular capillary hydrostatic pressure (~60 mmHg) is the primary driving force for filtration |
| e) Increase in renal blood flow | T | Increased RBF raises glomerular capillary pressure → increases GFR |
Q6. Transcellular Fluid Includes —
| Statement | T/F | Explanation |
|---|
| a) Bile | T | Bile is a transcellular fluid (secreted by hepatocytes into bile canaliculi — a specialized compartment) |
| b) Cerebrospinal fluid | T | CSF is transcellular fluid (secreted by choroid plexus into a distinct compartment) |
| c) Lymph | F | Lymph is not transcellular; it is derived from interstitial fluid drained by lymphatic capillaries (part of ECF) |
| d) Plasma | F | Plasma is intravascular fluid — part of ECF, not transcellular |
| e) Synovial fluid | T | Synovial fluid is transcellular fluid (secreted into joint space by synovial cells) |
(Other transcellular fluids: aqueous humor, pericardial, pleural, peritoneal, gastrointestinal secretions)
Q7. Plasma Potassium —
| Statement | T/F | Explanation |
|---|
| a) decreases in diarrhea | T | Diarrhea → large K⁺ losses in stool → hypokalemia |
| b) decreases in insulin therapy | T | Insulin stimulates Na⁺/K⁺-ATPase → drives K⁺ into cells → plasma K⁺ falls (used to treat hyperkalemia) |
| c) decreases in renal failure | F | Renal failure → decreased K⁺ excretion → hyperkalemia (K⁺ increases) |
| d) increases in tissue damage | T | Tissue damage/cell lysis → intracellular K⁺ released into plasma → hyperkalemia (e.g., rhabdomyolysis, tumor lysis) |
| e) increases in acidosis | T | In acidosis, H⁺ enters cells → K⁺ exits cells to maintain electroneutrality → plasma K⁺ rises (hyperkalemia in acidosis) |
Q8. Positive Nitrogen Balance Occurs In —
(Positive nitrogen balance = nitrogen intake > nitrogen excretion; i.e., net protein anabolism)
| Statement | T/F | Explanation |
|---|
| a) diabetes mellitus | F | DM → protein catabolism → negative nitrogen balance |
| b) malignancy | F | Cancer → increased catabolism → negative nitrogen balance (cachexia) |
| c) growth period | T | Growing children, adolescents → net protein synthesis → positive N balance |
| d) starvation | F | Starvation → gluconeogenesis uses amino acids → negative N balance |
| e) pregnancy | T | Pregnancy → fetal growth, uterine/breast tissue growth → positive N balance |
(Also positive N balance: recovery from illness, anabolic steroid use, bodybuilding/resistance training)
Q9. TAG-Rich Lipoproteins Are —
(TAG = Triacylglycerol / Triglycerides)
| Statement | T/F | Explanation |
|---|
| a) LDL | F | LDL is cholesterol-rich (~45% cholesterol esters); only ~10% TAG |
| b) VLDL | T | VLDL is the primary endogenous TAG carrier (~55–65% TAG); secreted by liver |
| c) CM (Chylomicrons) | T | Chylomicrons are the primary dietary (exogenous) TAG carrier (~85–90% TAG); from intestine |
| d) HDL | F | HDL is protein-rich and cholesterol ester-rich; low in TAG |
| e) CMR (Chylomicron Remnants) | F | CMR have already had most TAG removed by lipoprotein lipase; relatively cholesterol-rich |
Q10. Causes of Hypotonic Hypervolemia —
(Hypotonic hypervolemia = increased total body water with low plasma osmolality/Na⁺ — too much hypotonic water retained)
| Statement | T/F | Explanation |
|---|
| a) nephrotic syndrome | F | Nephrotic syndrome → isotonic hypervolemia (edema with normal or low Na⁺ — typically hypoalbuminemia, but Na⁺ is not extremely low; it's more of a redistributional edema) — more accurately hypovolemic hyponatremia |
| b) sea water intake | F | Sea water is hypertonic → drinking it causes hypertonic hypervolemia/dehydration (worsens dehydration) |
| c) Cushing's syndrome | F | Cushing's → isotonic fluid retention (mineralocorticoid effect → Na⁺ and water retention proportionally); mild hypernatremia/normonatremia |
| d) protein-losing enteropathies | F | These cause hypoalbuminemia → edema (redistributional), but not primary hypotonic hypervolemia |
| e) chronic renal failure | T | CRF → inability to excrete water → dilutional hyponatremia → hypotonic hypervolemia |
(Classic cause of hypotonic hypervolemia: SIADH — water retained disproportionately; also fresh water drowning, excessive hypotonic IV fluids, psychogenic polydipsia)
Quick Reference Summary — MCQ T/F Answers
| Q | a | b | c | d | e |
|---|
| 1 Cholesterol | F | T | F | F | T |
| 2 HMP Shunt | F | F | F | F | T |
| 3 Ketone Bodies | F | T | T | F | F |
| 4 Proteolytic Enzymes | T | F | T | F | T |
| 5 GFR Favoring Forces | F | F | T | T | T |
| 6 Transcellular Fluid | T | T | F | F | T |
| 7 Plasma Potassium | T | T | F | T | T |
| 8 Positive N Balance | F | F | T | F | T |
| 9 TAG-rich Lipoproteins | F | T | T | F | F |
| 10 Hypotonic Hypervolemia | F | F | F | F | T |
Note: The SBA questions 11–20 were not visible in the image provided. If you can share those, I'll answer them too. All answers above are based on standard biochemistry and physiology (Harper's Biochemistry, Ganong's Physiology, Lehninger's Principles of Biochemistry).